Matthias G. Wacker

Matthias G. Wacker is an Associate Professor at the Department of Pharmacy and Pharmaceutical Sciences of the National University of Singapore (NUS), where he contributes to research and education in the field of pharmaceutical sciences. He earned his Ph.D. in pharmaceutical technology from Goethe University Frankfurt, Germany, and completed his habilitation at the Institute of Pharmaceutical Technology under the guidance of Jennifer Dressman and Jörg Kreuter. Before joining NUS, he led the Department of Pharmaceutical Technology and Nanosciences at the Fraunhofer Institute for Molecular Biology and Applied Ecology (IME).

​

His research focuses on in vitro testing and the characterization of complex dispersed dosage forms, with particular interest in biopredictive release methods, in vitro-in vivo correlations (IVIVC), the process of disassembly in physiological environments. He applies a quality-by-design approach and uses computational modeling to support formulation development and improve translational success.

​

Prof. Wacker contributes to several international scientific and regulatory initiatives, including expert committees of the United States Pharmacopeial Convention and the ISO Technical Committee 229 on nanotechnology standards. He also serves on the editorial boards of journals such as the European Journal of Pharmaceutics and Biopharmaceutics, the European Journal of Pharmaceutical Sciences, the Journal of Pharmacy and Pharmacology, and is Associate Editor of Frontiers in Chemistry.

 

His work has been recognized by awards such as the Eudragit® Best Paper Award and the Phoenix Pharmaceutics Science Award. Since 2022, he has been listed every year among the World’s Top 2% of Scientists by the Stanford University Ranking.